Hansa Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
07 Dec 23 | BuyUS$11,066 | Søren Tulstrup | Individual | 5,000 | US$2.21 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 644,800 | 1.02% |
Individual Insiders | 4,685,041 | 7.42% |
Institutions | 9,609,771 | 15.2% |
Hedge Funds | 15,558,714 | 24.6% |
General Public | 32,648,210 | 51.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,445,764 | US$47.2m | -2.15% | 1.85% | |||
6,112,950 | US$30.5m | 527% | 1.83% | |||
2,155,379 | US$10.8m | 0% | 40.95% | |||
2,100,000 | US$10.5m | 0% | no data | |||
1,917,000 | US$9.6m | 0% | no data | |||
1,700,000 | US$8.5m | 0% | 0.03% | |||
1,510,968 | US$7.5m | -14.4% | 0.17% | |||
1,389,650 | US$6.9m | 0% | 0.03% | |||
879,183 | US$4.4m | 0% | 0.01% | |||
799,749 | US$4.0m | 0% | 0.03% | |||
725,000 | US$3.6m | 0% | 100.0% | |||
667,169 | US$3.3m | 0% | 1.4% | |||
644,800 | US$3.2m | 0% | no data | |||
600,000 | US$3.0m | 0% | no data | |||
335,579 | US$1.7m | 0% | no data | |||
286,384 | US$1.4m | 0% | no data | |||
180,714 | US$902.5k | 0% | no data | |||
179,006 | US$893.9k | 0% | 0.01% | |||
164,340 | US$820.7k | 0% | no data | |||
151,727 | US$757.7k | 0.59% | no data | |||
127,186 | US$635.1k | 0% | 0.2% | |||
46,000 | US$229.7k | 0% | 0.04% | |||
44,173 | US$220.6k | 0% | no data | |||
31,541 | US$157.5k | 0% | no data | |||
24,500 | US$122.4k | 69% | no data |